biotech · Breast Cancer · Sarcoma,Soft Tissue · INTS
INTENSITY THERAPEUTICS
INTENSITY THERAPEUTICS, INC.
INTENSITY THERAPEUTICS patent portfolio — 3 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Shelton, USA HQ
2012 Founded
12 Employees
Public company Type
INTS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Shelton, USA
- Founded
- 2012
- Employees
- 12
- Programs
- 6
- Drugs
- 9
- Patents
- 3
INTENSITY THERAPEUTICS patents
3 pharmaceutical patents indexed for INTENSITY THERAPEUTICS. 0 expire within 24 months.
INTENSITY THERAPEUTICS has 3 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does INTENSITY THERAPEUTICS have?
3 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do INTENSITY THERAPEUTICS patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.